AR and prostate carcinoma: Downregulation of AR expression during prostate cancer progression (Segawa et al, 2001) and increased expression with the development of hormone refractory tumours (Trapman and Cleutjens, 1997; Latil et al, 2001; Linja et al, 2001) have both been reported.